Further Evaluation of Potential Caps in Part D Shows Promise for Beneficiary Impact
A recently released report from the Urban Institute shows that a firm limit on out-of-pocket (OOP) Part D costs, like
Medicare Watch articles are featured in Medicare Rights’ weekly newsletter, which helps readers stay updated on Medicare policy and advocacy developments and learn about changes in Medicare benefits and rules. Subscribe now by visiting www.medicarerights.org/newsletters.
A recently released report from the Urban Institute shows that a firm limit on out-of-pocket (OOP) Part D costs, like
Last week, the Biden-Harris Administration submitted its annual budget request to Congress. While presidential budget requests are not binding on
On Monday, the Centers for Medicare and Medicaid Services (CMS) announced that for the duration of the COVID-19 public health
This week, a report out of The Heller School for Social Policy and Management at Brandeis University and the Community
A data spotlight from the Consumer Financial Protection Bureau (CFPB)—the federal agency that enforces consumer financial law—shows that medical debt
A new brief from the Kaiser Family Foundation (KFF) examines the often extreme cost liability that Part B covered drugs—typically,
This week, the Medicare Payment Advisory Commission (MedPAC) delivered its annual report to Congress that examines Medicare’s payment policies, including
A new analysis from the AARP Public Policy Institute finds drug companies have increased prices for many brand name Part
This week, Medicare Rights submitted comments on a proposed rule that would make some important changes to Medicare Advantage (MA)
The Centers for Medicare & Medicaid Services (CMS) recently announced changes to its Accountable Care Organization (ACO) model portfolio that
A recently released report from the Urban Institute shows that a firm limit on out-of-pocket (OOP) Part D costs, like
Last week, the Biden-Harris Administration submitted its annual budget request to Congress. While presidential budget requests are not binding on
On Monday, the Centers for Medicare and Medicaid Services (CMS) announced that for the duration of the COVID-19 public health
This week, a report out of The Heller School for Social Policy and Management at Brandeis University and the Community
A data spotlight from the Consumer Financial Protection Bureau (CFPB)—the federal agency that enforces consumer financial law—shows that medical debt
A new brief from the Kaiser Family Foundation (KFF) examines the often extreme cost liability that Part B covered drugs—typically,
This week, the Medicare Payment Advisory Commission (MedPAC) delivered its annual report to Congress that examines Medicare’s payment policies, including
A new analysis from the AARP Public Policy Institute finds drug companies have increased prices for many brand name Part
This week, Medicare Rights submitted comments on a proposed rule that would make some important changes to Medicare Advantage (MA)
The Centers for Medicare & Medicaid Services (CMS) recently announced changes to its Accountable Care Organization (ACO) model portfolio that